Ilaria Colombo

14PUBLICATIONS

63CO-AUTHORS

ChemotherapySolid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|May 13, 2026

Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial.

|Jan 12, 2026

Giant Primary Hepatic Endodermal Sinus Tumor: Multidisciplinary Management and Long-Term Survival.

Katia Roque, Rossana Ruiz, Renier Cruz

|Nov 18, 2025

TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16).

Marian Klose, Ilaria Colombo, Katrin Gobat

|Nov 10, 2025

Bispecific antibodies in the treatment of epithelial ovarian, endometrial, and cervical cancer: an overview of current applications, challenges, and emerging opportunities.

Sara Parola, Ilaria Colombo

|Jun 26, 2025

A Retrospective Assessment of Computed Tomography-Based Body Composition and Toxicity in Ovarian Cancer Patients Treated with PARP Inhibitors.

Marta Nerone, Giorgio Raia, Maria Del Grande

|Jul 05, 2024

Clinical relevance of circulating tumor DNA in ovarian cancer: current issues and future opportunities.

Elena Trevisi, Cristiana Sessa, Ilaria Colombo

Pageof 3

Frequent Collaborators

Cristiana Sessa

Maria Del Grande

Federica Martorana

Lucia Manganaro

Marta Nerone

Stefania Rizzo

Ainhoa Madariaga

Filippo Del Grande

Giorgio Raia

Amit M Oza

Frequent Collaborators

Cristiana Sessa

Maria Del Grande

Federica Martorana

Lucia Manganaro